The present results indicate that IDC and ILC, although both defined as hormone-responsive tumours (ER+ and/or PgR+ in 84 and 97% of cases, respectively), are characterised by a different biological profile in which proteins related to hormone responsiveness, cell-cycle control, apoptosis and angiogenesis are differently integrated. The gene discussed is CCL27; the disease is neoplasm.